(Q40621162)

22 September 2017

1 reference

title

New concepts in dopamine receptor plasticity (English)

1 reference

22 September 2017

LaHoste GJ

1

1 reference

22 September 2017

Marshall JF

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

Annals of the New York Academy of Sciences

22 September 2017

published in

1 reference

22 September 2017

volume

702

1 reference

22 September 2017

page(s)

183-196

1 reference

New frontiers in basal ganglia research. Introduction

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Multiple dopamine receptors and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Brain Function: Neural Adaptations and Recovery From Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Molecular biology of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Dopamine receptor gene expression by enkephalin neurons in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: Autoradiographic evidence against the dual mechanism hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Decreased striatal D1 binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Central D1- and D2-receptor occupancy during antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1993.TB17248.X

10.1111/J.1749-6632.1993.TB17248.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference